The first stop for professional medicines advice

Ephedrine

Published
Topics: Cardiovascular system disordersEar, nose and throat disordersEphedrine · Respiratory disordersSafety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Medicine Compliance Aid Stability
    1. generic · Wockhardt UK Ltd
  3. Lactation Safety Information
    1. Parenteral
    2. Intranasal
    3. Oral · for reversible airways obstruction

dm+d

65026000

Medicine Compliance Aid Stability

genericWockhardt UK Ltd

Wockhardt UK Ltd
generic
Tablet 15mg, 30mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Ephedrine and ephedrine salts gradually decompose and darken on exposure to light.
25 October 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Parenteral

Parenteral
Caution
-
No published evidence of safety
Short-term use not considered to pose risk to breastfed infant
Safety in Lactation: Sympathomimetics for acute cardiac conditions
30 July 2020
Bibliography

Intranasal

Intranasal
Caution
Xylometazoline
Minor adverse effect reported in infants with pseudoephedrine
Short-term use considered to present negligible risk to a breastfed infant. Theoretical risks may increase with longer-term use
Safety in Lactation: Topical nasal decongestants
30 July 2020

Oral for reversible airways obstruction

Oral
for reversible airways obstruction
Caution
Salbutamol/ Terbutaline or corticosteroid inhaler
Adrenoceptor agonist for reversible airways obstruction
No published evidence of safety
Case report of irritability, excessive crying, and disturbed sleeping patterns in a breastfed infant possibly due to an isomer of ephedrine
Safety in Lactation: Drugs for obstructive airways disease
30 July 2020
Bibliography